Agios Pharmaceuticals Inc. (AGIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Agios Pharmaceuticals Inc...

    NASDAQ: AGIO · Real-Time Price · USD
    36.01
    -0.12 (-0.33%)
    At close: Sep 05, 2025, 3:59 PM
    36.01
    0.00%
    After-hours: Sep 05, 2025, 04:42 PM EDT

    Agios Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 36.5M 26.82M 14.24M n/a
    Cost of Revenue
    		 4.17M 9.5M 1.7M 18.78M
    Gross Profit
    		 32.33M 17.32M 12.54M -18.78M
    Operating Income
    		 -425.74M -391.49M -389.05M -378.42M
    Interest Income
    		 48.08M 33.34M 12.79M 836K
    Pretax Income
    		 717.97M -352.09M -231.8M -356.51M
    Net Income
    		 673.73M -352.09M -74.56M 1.6B
    Selling & General & Admin
    		 156.78M 119.9M 121.67M 121.44M
    Research & Development
    		 301.29M 288.9M 279.91M 256.97M
    Other Expenses
    		 n/a n/a n/a 14.43M
    Operating Expenses
    		 458.07M 408.81M 401.58M 378.42M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 462.24M 418.31M 403.29M 378.42M
    Income Tax Expense
    		 44.24M n/a -157.25M n/a
    Shares Outstanding (Basic)
    		 56.81M 55.65M 54.79M 60.45M
    Shares Outstanding (Diluted)
    		 57.89M 55.65M 54.79M 60.45M
    EPS (Basic)
    		 11.86 -6.33 -1.36 26.55
    EPS (Diluted)
    		 11.64 -6.33 -1.36 26.55
    EBITDA
    		 -425.74M -384.86M -380.48M -337.73M
    EBIT
    		 -425.74M -391.49M -389.05M -356.51M
    Depreciation & Amortization
    		 5.65M 6.62M 18.56M 18.78M

    Add to Watchlist